Ducommun earnings up next: Can defense offset aerospace drag?

Ducommun is expected to report Q1 EPS of $0.85 on revenue of $199.65 million, implying modest year-over-year growth but a sequential decline from Q4’s $1.05 EPS and $216 million revenue. Investors are focused on whether defense demand, which drove 20% missile portfolio sales growth and a 1.8x defense book-to-bill in Q4, can offset 7% full-year commercial aerospace weakness from 737MAX destocking. Goldman Sachs raised its price target to $151, though EPS estimates have fallen 1.39% over the past 60 days, signaling some caution.

Analysis

DCO is transitioning from a cyclical supplier to a leverage play on defense replenishment, but the market is already paying for that narrative. The key second-order effect is that defense mix improvement can mask underlying commercial softness for longer than investors expect, allowing margins to hold even if top-line growth decelerates; that makes the print less about EPS and more about whether backlog converts without working-capital drag. If management confirms continued missile/space order strength, the stock can re-rate on durability rather than growth alone.

The risk is that the setup is asymmetrically sensitive to any hint of normalization in defense book-to-bill or another quarter of commercial destocking. Because the shares are near prior highs, a modest miss on revenue or margin can compress multiple quickly over the next 1-3 sessions, especially given the small residual upside to consensus targets. The more important medium-term catalyst is guidance: if 2H26 commercial recovery is pushed out, the market will stop capitalizing VISION 2027 as a near-term path and start treating it as execution-dependent.

GS’s own target revision suggests the sell-side is not debating the trend, only the magnitude, which is often a warning sign late in a rerating. Consensus likely underestimates how much of DCO’s current valuation depends on sustained defense ordering into 2026; if that ordering remains intact, the downside from a merely “good” quarter may be limited, but if it cracks even slightly the stock can de-rate faster than fundamentals change. The setup argues for trading around the print, not owning it blindly into an elevated expectations event.

Key Decisions for Investors

• Short-dated DCO straddle/strangle into earnings only if implied move remains below the likely post-print range; the setup favors a volatility event with asymmetric gap risk in either direction.
• If long DCO, reduce position into the print and re-enter only on confirmation that defense backlog and margin expansion remain intact; avoid holding full size through a guidance-sensitive quarter near highs.
• For event-driven longs, buy DCO only on a post-earnings pullback toward the prior breakout area, with a 2-3 month horizon; downside should be capped if defense demand stays >1.5x book-to-bill, while upside extends if commercial recovery is reiterated.
• Pair trade: long DCO / short a weaker commercial-aerospace supplier over 1-2 quarters; DCO’s defense mix should protect margins better if commercial demand remains choppy.
• If management sounds cautious on 2H26 commercial recovery, use any initial pop to fade DCO via call spreads rather than outright shorting; momentum can persist, but the valuation leaves little room for a miss.